Neurology News

The FDA has approved Daybue for the treatment of Rett syndrome in patients aged 2 years and older, making it the first and only approved treatment for the genetic disorder, according to an Acadia Pharmaceuticals press release.

Let’s start by getting to the point. You should call your bank and find out what you are making on your cash.

On Saturday night, most of us in the U.S. will lose an hour of sleep as we switch to daylight saving time.

The FDA has approved Pfizer’s Zavzpret, a calcitonin gene-related peptide receptor antagonist nasal spray to treat migraine with or without aura in adults.

The FDA has granted de novo approval to Neuromod Devices’ Lenire, a noninvasive device for the treatment of tinnitus and the first of its kind to receive approval in the United States, according to a company press release.

Hopefully you’ve forgiven us for talking so much about tax, although by now you realize why it was so important that we did.

An “undercurrent of racism” runs throughout academic medicine, resulting in not only “disillusionment and attrition,” but also internalized racism among underrepresented groups, according to a letter published in The Lancet.

Individuals who consumed MIND and Mediterranean diets had fewer amyloid plaques and tau tangles in their brain, which are indicators of Alzheimer’s disease, according to researchers.

A new machine learning model that incorporates cardiac activity and body movement may help estimate the severity of Rett syndrome symptoms, enabling researchers to identify effective treatments, according to findings published in PLOS ONE.

The Biden administration recently released its proposed 2024 federal budget, which would extend the solvency of Medicare by 25 years while reducing behavioral health and medication costs for beneficiaries.